Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nomografia (Matemàtica)"'
Autor:
Michele Reni, David Goldstein, Chrystal U. Louis, Josep Tabernero, Marc F. Botteman, Abdalla Aly, Chee Khoon Lee, Daniel D. Von Hoff, Sandra Margunato-Debay, Desmond McGovern, Brian Lu, E. Gabriela Chiorean, Ramesh K. Ramanathan
Publikováno v:
Pancreas
Scientia
Scientia
Supplemental digital content is available in the text.
Objectives This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. Methods Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenoca
Objectives This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. Methods Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenoca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452c5bb5e6c9eb47f85549a3cb03f05a
https://doi.org/10.1097/mpa.0000000000001563
https://doi.org/10.1097/mpa.0000000000001563
Autor:
Giuseppe Curigliano, Michael J. Overman, Massimiliano Salati, Chiara Cremolini, Aakash Tushar Shah, Gabriele Infante, Sara Lonardi, Rossana Intini, Priya Jayachandran, Giovanni Fucà, Floriana Nappo, Rosalba Miceli, Marwan Fakih, Francesca Corti, Lisa Salvatore, Federica Morano, Javier Ros, Filippo Pietrantonio, Margherita Ambrosini, Elisabetta Fenocchio, Silvia Damian, Maria Elena Elez
Publikováno v:
Scientia
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Neoplasias gastrointestinales; Inmunoterapia Neoplàsies gastrointestinals; Immunoteràpia Gastrointestinal neoplasms; Immunotherapy Background The efficacy of immune checkpoint inhibitors (ICIs) in patients with microsatellite instability (MSI)-high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24c8cbd2319d4ea7771de79ebb64444
https://hdl.handle.net/11351/7373
https://hdl.handle.net/11351/7373
Autor:
[Chen LT ] National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. [Macarulla T] Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d'Hebron Institut d'Oncologia (VHIO), Barcelona, Spain. [Blanc JF] Groupe Hospitalier Haut-Lévêque, CHU Bordeaux, Pessac, France. [Mirakhur B] Ipsen Biopharmaceuticals, Inc., Basking Ridge, USA. [Jong FA] Global Medical Affiars, Servier, Zürich, Switzerland. [Belanger B] Ipsen Biopharmaceuticals, Inc., Cambridge, USA, Hospital Universitari Vall d'Hebron
Publikováno v:
Scientia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______272::8100e449e86e82e07880198f186a322e
https://hdl.handle.net/2072/433689
https://hdl.handle.net/2072/433689
Autor:
Reigetsu Yoshikawa, Peter R. Galle, Chunxiao Wang, Arndt Vogel, Kenta Shinozaki, Richard S. Finn, Yi Hsiang Huang, Yoon-Koo Kang, Stephen L. Chan, Daniel H. Palmer, Giovanni Brandi, Eric Assenat, Chia Jui Yen, Masatoshi Kudo, Masafumi Ikeda, Philippe Merle, Ryan C. Widau, Paolo Abada, Tatsuya Yamashita, Andrew X. Zhu, Josep M. Llovet
Publikováno v:
JHEP Reports, Vol 3, Iss 2, Pp 100215-(2021)
Dipòsit Digital de la UB
Universidad de Barcelona
JHEP Reports
Dipòsit Digital de la UB
Universidad de Barcelona
JHEP Reports
Background & Aims The albumin–bilirubin (ALBI) grade/score is derived from a validated nomogram to objectively assess prognosis and liver function in patients with hepatocellular carcinoma (HCC). In this post hoc analysis, we assessed prognosis in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3529e6ed991569dbb4a260a7328ae4e
http://hdl.handle.net/11585/875982
http://hdl.handle.net/11585/875982
Autor:
Beloo Mirakhur, Jean-Frédéric Blanc, Floris A. de Jong, Tanios Bekaii-Saab, Teresa Macarulla, Bruce Belanger, Jens T. Siveke, Li-Tzong Chen
Publikováno v:
Cancers
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Volume 11
Issue 8
Recercat. Dipósit de la Recerca de Catalunya
instname
Cancers, Vol 11, Iss 8, p 1068 (2019)
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Volume 11
Issue 8
Recercat. Dipósit de la Recerca de Catalunya
instname
Cancers, Vol 11, Iss 8, p 1068 (2019)
NAPOLI-1; Liposomal irinotecan; Survival outcomes NAPOLI-1; Irinotecan liposòmic; Resultats de supervivència NAPOLI-1; Irinotecan liposomal; Resultados de supervivencia NAPOLI-1 (NCT01494506) was a phase III study of liposomal irinotecan (nal-IRI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbd8e08bb5d74aa1c0bb1fd973ab9c7
https://doi.org/10.3390/cancers11081068
https://doi.org/10.3390/cancers11081068